NEDD9 may influence CLL homing and chemotaxis by causing changes in surface expression of the prominent cell trafficking mediators CXCR2, CD44, VLA-4, and CXCR4. The gene discussed is CXCR2; the disease is B-cell chronic lymphocytic leukemia.